当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202014
编号:13477945
miRNA-132通过靶向PDCD4在多发性骨髓瘤细胞黏附介导的耐药性中的作用(4)
http://www.100md.com 2020年5月15日 《中国医药导报》 202014
     [12] Liang SH,Yeh SP. Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone [J]. Ann Hematol,2019,98(10):2447-2450.

    [13] Marin EH,Paek H,Li M,et al. Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells [J]. Invest New Drugs,2019,37(5):837-848.

    [14] Wu S,He X,Li M,et al. MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2 [J]. Am J Transl Res,2016,8(14):125-132.

    [15] 武丽芳,杜剑峰.miR-132在神经胶质瘤中表达及临床意义[J].神经损伤与功能重建,2017,12(3):221-224.

    [16] Jia M,Wang X,Zhang H,et al. MicroRNA-132 in the adult dentate gyrus is involved in opioid addiction via modifying the differentiation of neural stem cells[J]. Neurosci Bull,2019,35(3):486-496.

    [17] Diao X,Zhou J,Wang S,et al. Upregulation of miR-132 contributes to the pathophysiology of COPD via targeting SOCS5 [J]. Exp Mol Pathol,2018,6(12):142-151.

    [18] Zhang H,Lin J,Hu T,et al. Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line [J]. J Pharmacol Sci,2019,139(3):186-192.

    [19] 衛江华,许刚,关哲,等.骨肉瘤患者血清miRNA-21水平与化疗敏感性和预后的相关性[J].肿瘤研究与临床,2019,31(4):253-256.

    [20] Yang YN,Bian LQ,Ling XD,et al. MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4 [J]. Pathol Res Pract,2019,41(6):132-143.

    (收稿日期:2019-10-25 本文编辑:任 念), 百拇医药(周佳妮 马泳泳)
上一页1 2 3 4